Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials

Nagendran, Myura, Russell, James A., Walley, Keith R., Brett, Stephen J., Perkins, Gavin D., Hajjar, Ludhmila, Mason, Alexina J., Ashby, Deborah +1 more·2019·Intensive Care Medicine
DOI 10.1007/s00134-019-05620-2

Cited by (161)

Items 101–161 of 161

  1. Nierenversagen
    Jens Nentwich, Stefan John · 2021 · DMW - Deutsche Medizinische Wochenschrift
  2. Comparison of short-term and long-term renal function effects of vasopressin and norepinephrine in patients with septic shock: a systematic review and meta-analysis
    Hongyu Wang, Xilin Liu, Hong Zhang · 2025 · Frontiers in Pharmacology
  3. Management of post-resuscitation vasoplegic shock: targets, strategies and outcomes
    Ali Jendoubi, Quentin de Roux, Alain Cariou, Fabio Silvio Taccone, Bijan Ghaleh, Renaud Tissier, Matthias Kohlhauer, Nicolas Mongardon · 2025 · Critical Care
  4. Early vasopressin administration in septic shock: A systematic review, meta-analysis, and multicenter retrospective observational study
    Chiwon Ahn, G S Lee, J H Kim, Sejoong Ahn, Sung Yeon Hwang, Sang-Min Kim, Won Young Kim, S M Park, Sung-Hyuk Choi, Woon Yong Kwon et al. · 2026 · European Journal of Internal Medicine
  5. Therapie der Sepsis
    Frank Bloos · 2023 · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
  6. Agentes vasoactivos en sepsis: revisión crítica de la literatura
    Julian Esteban Barahona Correa, Vanessa Pérez Carrillo, Julián Rondón-Carvajal, Andrés Laserna · 2023 · Universitas Médica
  7. Use of methylene blue in adult patients with septic shock: a systematic review and meta-analysis
    Ka Ting Ng, Pei En Kwok, Wei En Lim, Wan Yi Teoh, Mohd Shahnaz Hasan, Mohd Fitry Zainal Abidin · 2024 · British Journal of Anaesthesia
  8. Fármacos vasoactivos en el tratamiento del shock séptico
    David Andaluz‐Ojeda, María Luisa Cantón‐Bulnes, C. Pey Richter, José Garnacho‐Montero · 2022 · Medicina Intensiva (English Edition)
  9. Renal dysfunction in surgical patients
    Hendrik Booke, Alexander Zarbock, Melanie Meersch · 2024 · Current Opinion in Critical Care
  10. Vasoaktive Substanzen im septischen Schock – individualisierte Strategien
    Georg Franz Lehner, Timo Mayerhöfer, Fabian Perschinka, Bernhard Benda, Michael Joannidis · 2025 · Medizinische Klinik - Intensivmedizin und Notfallmedizin
  11. Vasopressin
    Deborah C. Silverstein, Samantha K. Hart · 2023 · Small Animal Critical Care Medicine
  12. Vasopressin im distributiven Schock
    S. Bayerl, Tobias Wöhrle, Erich Kilger · 2020 · Der Anaesthesist
  13. Diabetes Insipidus after Vasopressin Withdrawal: A Scoping Review
    Marina Verçoza Viana, Raquel Stocker Pérsico, Luciana Verçoza Viana · 2022 · Indian Journal of Critical Care Medicine
  14. Management of AKI: Vasopressors
    Paolo Persona, Tommaso Pettenuzzo · 2024 · Springer eBooks
  15. Vasoactive drug use in children with community acquired septic shock in Australia and New Zealand
    Elliot Long, Stephen J. C. Hearps, Amanda Williams, Ben Gelbart, Warwick Butt, Thomas Rozen, Sarah McNab, Meredith Louise Borland, Simon Erickson, Shefali Jani et al. · 2025 · The Lancet Regional Health - Western Pacific
  16. Practical Tips for Clinical Stabilization in Septic Shock
    Ashish Kumar Khanna, Patrick M. Wieruszewski · 2026 · Critical Care Medicine
  17. The usual suspects: a pragmatic framework to identify and address reversible contributors in apparent refractory septic shock
    Paulo Melo, Pedro David Wendel‐Garcia, Marc Léone, Ashish Kumar Khanna, Sebastian Morales, Gustavo A. Ospina-Tascón, Ricardo Castro, Glenn Hernández P, Eduardo Kattan · 2026 · Critical Care
  18. Terlipressin for refractory septic shock: a study protocol of a single center, placebo-controlled double-blind phase III RCT (The TERESEP study).
    Thipdhorn Aritajati, Chawanee Chayakul, Surat Tongyoo · 2022 · Clinical Critical Care
  19. Transient diabetes insipidus after vasopressin discontinuation in cystic fibrosis with septic shock
    Natnicha Leelaviwat, Juthipong Benjanuwattra, Ahmed Elkheshen, Nouran Eshak, Marawan Elmassry, Mahmoud Hassan Abdelnabi · 2022 · Baylor University Medical Center Proceedings
  20. Adjunctive Vasopressors in Patients with Septic Shock: Protocol for a Systematic Review and Meta-Analysis
    Seth R. Bauer, Patrick M. Wieruszewski, Brittany D. Bissell, Siddharth Pawan Dugar, Gretchen L. Sacha, Ryota Sato, Matthew Siuba, Mary C. Schleicher, Vidula Vachharajani, Yngve T Falck-Ytter et al. · 2023 · medRxiv
  21. La Haute Autorité de santé prive les patients en choc septique de vasopressine : une perte de chance !
    Djillali Annane, Pierre‐Édouard Bollaert, Alexandre Demoule, Jean Paul Mira, Xavier Monnet, Jean–Louis Teboul, Antoine Vieillard‐Baron · 2019 · Médecine Intensive Réanimation
  22. Nouveautés dans les traitements du choc septique et état de la recherche
    Nicolas Herzog, Fanny Jouquand, Philippe Aries, Christophe Giacardi, Médéric Rouault · 2020 · La Revue de l Infirmière
  23. Vasopressors in Septic Shock: The Quest for Refinement
    Kishore Kumar Pichamuthu · 2022 · Indian Journal of Critical Care Medicine
  24. Letter to the editor: “Combination of norepinephrine with phenylephrine versus norepinephrine with vasopressin in critically ill patients with septic shock: A retrospective study”
    Wing-Sum Chan, Ching‐Tang Chiu, Yu‐Chang Yeh · 2022 · Journal of Critical Care
  25. An Overview of the Treatment Strategies of Extremities Ischemia in the Intensive Care Unit
    Tuğba Onur, Asiye Demırel · 2023 · Cureus
  26. Septic Shock
    Jan Bakker · 2023 · Lessons from the ICU
  27. Precision Medicine in Septic Shock
    Luis Chiscano‐Camón, Juan Carlos Ruiz‐Rodríguez, Ricard Ferrer · 2023 · Annual update in intensive care and emergency medicine
  28. Therapie der Sepsis
    Frank Bloos · 2023 · Intensivmedizin up2date
  29. Septic Acute Kidney Injury is Exacerbated by Norepinephrine
    Lou’i Al-Husinat, Alameen Alsabbah, Amer Abu Hmaid, Razan Athamneh, Majd Adwan, Mohammad N. Hourani, Seif Almakhadmeh, Zaid Jehad Al Modanat, Mohammed I. A. Ismail, Giustino Varrassi · 2023 · Vide Leaf, Hyderabad eBooks
  30. Estrategia integral de reanimación del paciente con sepsis y shock séptico
    L. del Río-Carbajo, Jorge Nieto-del Olmo, Paula Fernández‐Ugidos, Pablo Vidal · 2022 · Medicina Intensiva (English Edition)
  31. Clinical efficacy and safety of vasopressin and its analogues in patients with septic shock: a meta-analysis and trial sequential analysis
    Milan Dong, Shaojun Li, Jing Jiang, Dandan Pi, Jiashan Li, Xuehan Bai, Yiqi Lu, Feng Xu, Xuemei Li, Jing Li · 2024 · Research Square
  32. Pharmacological modulation of cardiac function and control of blood vessel calibre
    John Nicholls, Elliott Bertram-Ralph · 2024 · Anaesthesia & intensive care medicine
  33. Utilisation de la vasopressine et de ses analogues en réanimation
    Florian Blanchard, Adrien Picod · 2024 · Le Praticien en Anesthésie Réanimation
  34. Acute Kidney Injury in NeuroIntensive Care Unit
    Francesca Mulazzani, Beatrice Noè, Lisa Patrini, Giuseppe Citerio · 2024 · Elsevier eBooks
  35. Insights Into the Pathophysiology of Catecholamine-Refractory Shock: A Narrative Review
    Ana Gonçalves, Filipa Gonçalves Pereira, Susana Mendes Fernandes, João Gonçalves-Pereira · 2025 · Cureus
  36. Norepinephrine Dose Threshold at Vasopressin Initiation and Its Association With ICU Mortality in Septic Shock
    Jamil Antonio Cedeño, Pablo García-Olivares, Galo Francisco Castañeda, Carlos Tadeo Velazquez Ramirez, Arturo Rodríguez-Pérez, Javier Muñoz · 2025 · Research Square
  37. Ischemic necrosis of the tongue in a patient following vasopressor agents use and prolonged endotracheal intubation: A case report
    Seung-Heon Bae, Sung‐Tak Lee, Jin-Wook Kim · 2025 · 대한치과의사협회지
  38. When should we start vasopressin in septic shock? Revisiting an old question
    Javier Muñoz, Jamil Antonio Cedeño · 2025 · Journal of Intensive Medicine
  39. Inotropes and vasopressors (vasoactive drugs)
    Adam M. Deane, Ashish Kumar Khanna, John Myburgh · 2025 · Elsevier eBooks
  40. Additional file 1 of The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock
    J. Pedro Teixeira, Perez Ingles, David, J. Barton, James T. Dean, Pablo García, Susan J. Kunkel, Preeyaporn Sarangarm, Natalie K Weiss, Christopher L. Schaich, Busse, Laurence W. et al. · 2024 · Figshare
  41. Additional file 2 of Non-catecholamine vasopressors in the treatment of adult patients with septic shock—evidence from meta-analysis and trial sequential analysis of randomized clinical trials
    Zhong, Lei, Ji, Xiao-Wei, Wang, Hai-Li, Zhao, Guang-Ming, Zhou, Qing, Xie, Bo · 2020 · Figshare
  42. Additional file 4 of The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock
    J. Pedro Teixeira, Perez Ingles, David, J. Barton, James T. Dean, Pablo García, Susan J. Kunkel, Preeyaporn Sarangarm, Natalie K Weiss, Christopher L. Schaich, Busse, Laurence W. et al. · 2024 · Figshare
  43. Additional file 1 of Non-catecholamine vasopressors in the treatment of adult patients with septic shock—evidence from meta-analysis and trial sequential analysis of randomized clinical trials
    Zhong, Lei, Ji, Xiao-Wei, Wang, Hai-Li, Zhao, Guang-Ming, Zhou, Qing, Xie, Bo · 2020 · Figshare
  44. Additional file 3 of Non-catecholamine vasopressors in the treatment of adult patients with septic shock—evidence from meta-analysis and trial sequential analysis of randomized clinical trials
    Zhong, Lei, Ji, Xiao-Wei, Wang, Hai-Li, Zhao, Guang-Ming, Zhou, Qing, Xie, Bo · 2020 · Figshare
  45. Additional file 3 of The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock
    Teixeira, J. Pedro, Perez Ingles, David, J. Barton, James T. Dean, Pablo García, Susan J. Kunkel, Preeyaporn Sarangarm, Natalie K Weiss, Christopher L. Schaich, Busse, Laurence W. et al. · 2024 · Figshare
  46. Additional file 1 of Early administration of multiple vasopressors is associated with better survival in patients with sepsis: a propensity score-weighted study
    Tong, Xin, Xiaopeng Xue, Duan, Chuanzhi, Liu, Aihua · 2024 · Figshare
  47. Additional file 2 of The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock
    Teixeira, J. Pedro, Perez Ingles, David, J. Barton, James T. Dean, Pablo García, Susan J. Kunkel, Preeyaporn Sarangarm, Natalie K Weiss, Christopher L. Schaich, Busse, Laurence W. et al. · 2024 · Figshare
  48. Evidence Maps of Vasopressor Use in Adult Patients With Septic Shock: An Umbrella Review
    Fang Song, Cheng Xiao, Shengwen Song · 2026 · British Journal of Hospital Medicine
  49. Vasopressor-Induced Digital Ischemia: Management and Treatment Considerations
    Lacey Marie Smith, Gopal Ram Lalchandani, Gopal Ram Lalchandani · 2026 · The Journal Of Hand Surgery
  50. Early combination of terlipressin and norepinephrine in the treatment of patients with septic shock
    Zhenxing Ding, Mingqing Li, 陈渊源 Chen Yuanyuan · 2026 · Clinics
  51. Optimizing Timing and Dose of Starting Norepinephrine and Vasopressin in Septic Shock
    Gaku Hiroto, Mitsuaki Nishikimi, Nobuaki Shime · 2026 · Life
  52. Inotropic and vasopressor therapy in the intensive care unit: Physiopathology and evidence-based insights
    Nicolas Fage, Madjid Bouizegarene, Peter Radermacher, Pierre Asfar · 2026 · Hemodynamics
  53. Vasopressin Versus Norepinephrine As First-Line Vasopressor Therapy for Vasoplegic Shock Following Cardiac Surgery: A Systematic Review
    Aabha Divya, Niti Dalal, Grainne McKendry, Morgan Quinn, Aranya Bagchi, Adam A. Dalia, Kenneth Shelton · 2026 · Cureus
  54. Five things the intensivist cannot forget in the management of septic shock
    Carla Daniele Nascimento Pontes, Elisa Estenssoro, Flávia Ribeiro Machado · 2026 · Critical Care Science
  55. Challenges in evaluating associations among vasopressors, enteral nutrition, and nonocclusive mesenteric ischemia
    Angela L. Bingham, Brian L. Erstad · 2026 · American Journal of Health-System Pharmacy
  56. Association of Preexisting Atrial Fibrillation or Flutter With 30-Day Outcomes After Septic Shock: A Propensity-Matched Federated Database Study
    Dominique Rose Grayeb, Katherine Ripley, Navneet Gupta, PALWASHA ZAFAR, Anam Javed, Humza Saeed, Abu Baker Sheikh, Adeel Nasrullah · 2026 · Cardiology in Review
  57. Septic shock in the era of precision medicine: rethinking fluids, vasopressors, and immunomodulation
    Jialiang Du, Huizhen Feng, Shuangyong Dong, Chao Yang, Abdullah Y. Al-Danakh, Siding Zhou · 2026 · Frontiers in Medicine
  58. Early adjunctive vasopressin was not associated with a lower 7-day risk of renal replacement therapy in norepinephrine-treated patients with cirrhosis: a target-trial-informed study with external replication
    Wei Zhang, Keyan Miao, Hui Chen, Gang Lu, Ziyang Zhou, Jianguo Tang · 2026 · Frontiers in Pharmacology
  59. Effect of vasopressin and its analogues on microcirculatory perfusion: a systematic review
    Judith van Zwol, J. G. Kruijsse, A. A. Vidal Itriago, Sabrine N.T. Hemmes, Charissa E. van den Brom · 2026 · Intensive Care Medicine Experimental
  60. Effect of Vasopressin Initiation Threshold on Septic Shock Mortality
    Ithan D. Peltan, Danielle Groat, Jason R. Jacobs, Elisabeth H. Tillman, Carolyn Klippel, Ben J. Brintz, Stephanie Chauv, N. Arizmendez, Sarah J. Beesley, Jason R. Carr et al. · 2026 · JAMA
  61. Vasopressors Combination Therapy (Norepinephrine Plus Vasopressin Receptor Agonists) Improve Septic Shock Outcome: A Systematic Review and Meta-Analysis
    Weijie Yu, ZHANG Yanjie, Zhu Luo, Xin-Er Cai, Jiyue Shao, Wan‐Ting Lin, Jingyuan Xu · 2026 · Journal of Intensive Care Medicine